Healthcare Utilization and Out-of-Pocket Expenditure Among Adults With and Without Cancer in Korea-Analysis of the Korea Health Panel Survey [0.03%]
韩国成人癌症患者和非癌症患者的医疗利用及自付费用——基于韩国健康面板调查的分析
Durga Datta Chapagain,Vasuki Rajaguru,Do Hee Kim et al.
Durga Datta Chapagain et al.
Background: Cancer imposes substantial clinical and financial burdens worldwide. Although Korea operates a universal National Health Insurance system, concerns remain regarding healthcare utilization and out-of-pocket (OO...
Real-World Retrospective Analysis of Daratumumab for Relapsed or Refractory Multiple Myeloma in Regional Australia [0.03%]
达雷妥尤单抗治疗澳洲部分地区复发或难治性多发性骨髓瘤的疗效和安全性:基于登记数据库的事后研究分析
Benjamin Reardon,Ian Kerridge,Tasman Armytage
Benjamin Reardon
Daratumumab is widely used for relapsed or refractory multiple myeloma, yet outcomes from regional Australian centers remain underreported. This retrospective study evaluated real-world treatment patterns between 2018 and 2023 and survival ...
Established Prognostic Scores Predict Screen Failure But Not Post-Enrollment Outcomes in Phase 1 Oncology Trials: A Single Centre Retrospective Audit [0.03%]
一项单中心回顾性审核： established预后评分能够预测筛选失败，但不能预测一期临床试验中患者的入组后的结果
Ortis Estacio,Eve Malsem,Georgia McGuiness et al.
Ortis Estacio et al.
Background: Real-world safety and outcome data from Phase 1 trial populations-including screen failures-remain limited. We conducted a retrospective audit to evaluate the predictive utility of established Phase 1 prognost...
The Importance of Driver-Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit [0.03%]
重症监护病房初诊肺癌患者的驱动基因导向治疗的重要性
Yi-Chun Hsiao,Wei-Fan Ou,Po-Hsin Lee et al.
Yi-Chun Hsiao et al.
Background: Patients who had been diagnosed with lung cancer during intensive care unit (ICU) admission showed poor prognosis. This research investigated the clinical characteristics related to the outcomes of these patie...
Efficacy and Safety of Two-Weekly Enfortumab Vedotin in Combination With Pembrolizumab for Advanced Urothelial Carcinoma [0.03%]
替雷利珠单抗联合贝伐珠单抗治疗尿路上皮癌的疗效和安全性：一项II期研究
Ryunosuke Nakagawa,Kouji Izumi,Kazuki Toshima et al.
Ryunosuke Nakagawa et al.
Introduction: Enfortumab vedotin (EV) plus pembrolizumab (PEM) is a standard first-line therapy for advanced urothelial carcinoma (UC), but EV-related toxicities frequently lead to treatment modification or discontinuatio...
Identification of Methionine Metabolism-Driven Heterogeneous Subtypes in Colorectal Cancer and Their Associated Immune Microenvironment [0.03%]
结直肠癌中异柠檬酸脱氢酶突变亚型的免疫微环境差异性分析
Junhao Zhou,Wanhua Deng,Manzhao Ouyang
Junhao Zhou
Aim: Tumor heterogeneity, driven by metabolic reprogramming, challenges colorectal cancer (CRC) treatment. Methionine metabolism is crucial for tumor progression, but its role in CRC heterogeneity and the tumor immune mic...
Acute Toxicity With Trastuzumab Emtansine and Concurrent Radiotherapy: Non-Consecutive Case Series [0.03%]
曲妥珠单抗_emtansine联合放疗急性毒性：非连续病例系列研究
Philip Carroll,Jade Soo,Keelan Byrne et al.
Philip Carroll et al.
In the setting of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer, trastuzumab emtansine (T-DM1) is associated with improvements in both relapse-free and overall survival for patients with residual invasive dise...
Psychological Stress and Cancer Risk and Outcome: An Umbrella Review With Quantitative Synthesis [0.03%]
心理压力与癌症风险和预后：综述与定量合成
Fausto Petrelli,Chiara Abeni,Emanuela Ceruti et al.
Fausto Petrelli et al.
Purpose: Psychological stress, here used as an umbrella term encompassing depression, anxiety, psychosocial stress, stressful life events, perceived stress, and job strain, is hypothesized to influence cancer development ...
Benchmarking Cancer Quality Indicators by State in Australia: A Comparison of Cancer Care and Outcomes Between Queensland and Victoria [0.03%]
澳大利亚各州癌症质量指标的基准测试：昆士兰州和维多利亚州癌症护理和结果的比较
Tracey Guan,Danny R Youlden,Tommy Hon Ting Wong et al.
Tracey Guan et al.
Aims: Benchmarking quality indicators between jurisdictions provides an opportunity to identify unwarranted variations. This study compared statewide treatment and survival information for cancer between Queensland and Vi...